GLP-1 Receptor Agonist · Ozempic / Wegovy reference
What this peptide does at the cellular level, in plain words.
Binds the GLP-1 receptor in pancreas and CNS. Triggers glucose-dependent insulin secretion.
Modulates satiety centers in the hypothalamus. Early fullness, lower caloric intake.
Delays stomach content release. Sustains satiety for longer hours.
Improves HbA1c, reduces post-prandial spikes. Sensitizes to insulin.
Peptides often synergize. These are the most studied combinations with this product, and what outcome they target.
BPC-157 counters semaglutide GI side effects during titration.
While semaglutide cuts fat, CJC+Ipa preserves lean mass.
GHK-Cu improves skin elasticity during rapid weight loss.
Any combination must respect each peptide's protocol. If you have doubts about dosing or timing, message us before starting.
Semaglutide is a synthetic GLP-1 receptor agonist peptide widely used in metabolic and endocrine research. As the molecule behind Ozempic and Wegovy, semaglutide has been studied across more than 200 clinical trials, with documented effects on glucose regulation, appetite suppression, and body weight reduction in preclinical models.
SuperBio Labs Semaglutide is supplied as a lyophilized powder ≥99% pure, verified by HPLC and LC-MS analysis. Each batch ships with a third-party Certificate of Analysis documenting purity, peptide content, identity confirmation, and endotoxin levels (<1.0 EU/mg).
Researchers select semaglutide for its well-characterized mechanism of action: it activates GLP-1 receptors in the central nervous system and pancreas, modulating glucose-dependent insulin secretion, slowing gastric emptying, and reducing caloric intake in animal models. Its long half-life (~7 days) makes it the reference standard for once-weekly dosing protocols in research contexts.
For Research Use Only. Products supplied exclusively for research applications and laboratory use by qualified professionals.
We don't just hand you the vial. Every Semaglutide purchase includes everything you need to apply it safely, with a clear protocol and our team available 24/7.
Lyophilized · HPLC purity ≥99% · Batch with COA
Sterile diluent · 0.9% benzyl alcohol
21G needle · For peptide reconstitution
10mg → 5 · 20mg → 10 · 1×/week
10mg → 10 · 20mg → 20 · 2 per application (vial + skin)
Physical document · Reconstitution and dosing
8 steps · From opening the kit to application
App · Tracking · Human team 24/7
About supplies: the quantity of syringes and wipes adjusts automatically based on the presentation you choose. For extended cycles (BPC-157, GHK-Cu and similar) we cap supplies at 30 days — beyond that, 29G insulin syringes and 70% alcohol wipes are pharmacy items available without prescription in any city.
This is the conservative protocol included in the kit. We send it printed and digital, along with your access to SuperBio OS for tracking and support. If you have pre-existing medical conditions, consult a professional before starting.
Wk 1–4: 0.25mg → Wk 5–8: 0.5mg → Wk 9–12: 1.0mg → Wk 13+: 1.7–2.4mg
Apply on the same day each week. Rotate sites.
| Product | Semaglutide |
| CAS Number | 910463-68-2 |
| Molecular Weight | 4113.58 Da |
| Purity (HPLC) | ≥99% |
| Format | Lyophilized powder |
| Quantity | 10mg per vial |
| Endotoxin | <1.0 EU/mg |
| Storage | −20 °C, protected from light |
| Use | Research Use Only (RUO) |